Don't be fooled, page-24

First 24 Last

Share
Profile

Follow
drui

158 Posts.

1

09/08/17

16:34

Post #: 26394918
Share

Originally posted by Pardner ↑

I offer the following in response to the comments above.

The following table is in 2 parts:
1. Staff growth from acquisition and organic growth
2. Some financial metrics

View attachment 678897

The staff numbers are approximate only and the best I could do with the available information. They indicate that RXP's staff growth in the early years was almost solely driven by acquisition but in FY16 had a significant component of organic growth. Please note that I believe better assumption for FY16 is to assume a mix of staff growth of 50/50, approximately 155 in each category. This seems to indicate a move from acquisition based growth to a more organic growth strategy. The reduction in numbers in FY17 indicate a planned reduction in headcount.

The financial metrics show a decrease in EBITDA margin in FY15 but an increase in revenue per employee indicating an increase in costs of those employees. Note the trend is maintained in 2016. The metrics in FY17 indicate management's attempts to improve revenue quality.

Taken as a whole the indicates a more dynamic management strategy than is simply indicated by a simple "growth by acquisition" approach.

By the way; this debate has not only been enjoyable and informative for me it has diverted me from the temptation to buy more RXP shares and they have dropped from 90 cents to, currently, 82 cents - well done me!! I do expect the SP to fall below the placement offer price of 80.5 cents.

Expand

Great stuff Pardener, thanks for sharing that. I did slowly accumulate some more rxp today due to what I thought is attractive price.

I did sell most of mine at 90c mark and it is nice to get some back around 83 cents today.

I can't really see it fall under the CR price considering the overwhelming interest at that price. But then again they always fall back to the CR price for some reason.

RXP Price at posting: 81.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

AXP

Tambourah chases gold veins and mineralisation extension with drilling

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 15 more messages in this thread...

First 24 Last

Add RXP (ASX) to my watchlist

Don't be fooled, page-24

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Tambourah chases gold veins and mineralisation extension with drilling

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Featured News